PATENT CLAIM ANALYSIS

Application Number: 16073759
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-06
Patent Classification: ["514", "192000"]

Abstract:
New antimicrobials targeting L,D-transpeptidases, non-classical cysteine peptidases, have been developed and their unique chemical structures identified. Carbapenems and penems of the present invention are unique among β-lactams as they acylate and inhibit L,D-transpeptidases, which likely results in their superior antimicrobial potency. These new antimicrobial agents can be used alone, or in combination with other classic antimicrobial agents that target D,D transpeptidases, when treating bacterial infections.

Claim (Index 7):
The method of  claim 5  wherein the bacterial infection is one or more strains of bacteria that is resistant to antimicrobial agents directed to inactive D,D-transpeptidase.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 95.0
- Lexical Diversity: 1.33898
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14222338', '12180802', '13989600', '14888764', '14695813']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7307348481434324
- 35 USC 102 Novelty (BERT): 0.5235656664392615
- Combined Prediction Score: 0.7100179299730154
- Mean Citation Score: 228.733896
- Max Citation Score: 315.77783
- Similarity Product: 265.62711390506865

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test